Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-10-16 00:00:00 ET · period of report 2025-10-14 · accession 0001867899-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-16 | 2025-10-14 | KNSA | Tessari Eben | COO | S - Sale+OE | $37.67 | -12.4K | 28.7K | -30% | -$465.8K |
| D | 2025-10-16 | 2025-10-14 | KNSA | Tessari Eben | COO | M - OptEx | $8.83 | +6,500 | 41.1K | +19% | +$57.4K |
| D | 2025-10-16 | 2025-10-14 | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -6,500 | 12.5K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-10-14 | S | D | 11,815 | $37.65 | 29,237 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $36.98 and $37.97. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 2 | Common | Class A Ordinary Share | 2025-10-14 | S | D | 553 | $37.99 | 28,684 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $37.98 and $38.00. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Common | Class A Ordinary Share | 2025-10-14 | M | A | 6,500 | $8.83 | 41,052 | D | — | — | |
| 4 | Derivative | Share Option | 2025-10-14 | M | D | 6,500 | $0.00 | 12,500 | D | $8.83 · — to 2029-09-16 | 6,500 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |